Brief: Vicore Pharma Q1 EBIT SEK 23.2 Million
03/05/2024 07:00
May 03 (Reuters) - Vicore Pharma Q1 sales SEK 104.2 million. * Q1 adjusted EPS SEK 0.28 * Q1 net income SEK 31.7 million * Q1 adjusted free cash flow SEK 23.1 million * Q1 cash & investments SEK 512.2 million
Recent news on Vicore Pharma Holding AB
See all newsBrief: Vicore Pharma Holding Q3 Net Revenues Amounted To Sek 0.6 Mln
Brief: Vicore Pharma Holding AB Phase 2B Aspire Trial Of Buloxibutid In Ipf Passes Pre-Planned Futility Analysis, On Track For Mid-2027 Topline Results
Brief: Vicore Pharma Q2 Operating Loss At SEK 150.1 Million
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 01:53 PM
Brief: Vicore Pharma Shares Start Trading In US On July 2